Woodcock: Clinical Trial System is ‘Broken,’ Real-World Data, Master Protocols Are The Future

Drug Industry Daily
A A
The future of the pharmaceutical industry will involve increased use of master protocols, trial platforms and clinical-trial networks, said CDER director Janet Woodcock this week at a National Academies of Sciences, Engineering and Medicine workshop on real-world evidence in Washington, D.C.

To View This Article:

Login

Subscribe To Drug Industry Daily